Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Larazotide Acetate
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Recipient : Innovate Biopharmaceuticals
Deal Size : Undisclosed
Deal Type : Merger
Innovate Biopharmaceuticals and RDD Pharma Merge to Form 9 Meters Biopharma
Details : Innovative to change its name to 9 Meters Biopharma. 9 Biopharma meters to focus on delivering novel approach including the first and only long-acting GLP-1 agonist receptor for Short Bowel Syndrome.
Brand Name : Undisclosed
Molecule Type : Peptide
Upfront Cash : Undisclosed
April 30, 2020
Lead Product(s) : Larazotide Acetate
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Recipient : Innovate Biopharmaceuticals
Deal Size : Undisclosed
Deal Type : Merger
LOOKING FOR A SUPPLIER?